Emmaus Life Sciences, Inc. Stock Other OTC
Equities
EMMA
US29137T1016
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | 18.39M | Sales 2023 | 29.6M | Capitalization | 6.19M |
---|---|---|---|---|---|
Net income 2022 | -10M | Net income 2023 | -3M | EV / Sales 2022 | 2.27 x |
Net Debt 2022 | 28.8M | Net Debt 2023 | 30.1M | EV / Sales 2023 | 1.23 x |
P/E ratio 2022 |
-1.21
x | P/E ratio 2023 |
-1.42
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 41.83% |
Managers | Title | Age | Since |
---|---|---|---|
George Sekulich
PSD | President | 59 | 19-04-30 |
Willis Lee
CHM | Chairman | 64 | 19-07-16 |
Yasushi Nagasaki
DFI | Director of Finance/CFO | 57 | 11-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Peu Zen
BRD | Director/Board Member | 71 | 19-07-16 |
Willis Lee
CHM | Chairman | 64 | 19-07-16 |
Ian Zwicker
BRD | Director/Board Member | 77 | 19-07-16 |
1st Jan change | Capi. | |
---|---|---|
+16.59% | 44.44B | |
+42.55% | 40.03B | |
-10.62% | 37.68B | |
+29.92% | 31.46B | |
-9.23% | 27.29B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |